DELUCCIA ROBERT J - 06 Jan 2025 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role: Director, 10%+ Owner
Signature: /s/ Kostantinos Skordalos, Power of Attorney For: Robert J. DeLuccia
Issuer symbol: ACXP
Transactions as of: 06 Jan 2025
Transactions value $: $50,000
Form type: 4
Filing time: 08 Jan 2025, 16:30:38 UTC
Previous filing: 03 Apr 2024
Next filing: 06 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACXP	Common Stock	Purchase	$50,000	+49,261	+5.13%	$1.02	1,010,196	06 Jan 2025	Direct	F1
holding	ACXP	Common Stock						3,847	06 Jan 2025	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACXP	Warrants for Common Stock	Purchase	$0	+49,261		$0.000000	49,261	06 Jan 2025	Common Stock	49,261	$0.9000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
F2	Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.